Contact lens material containing macromolecular bioprotein monomer as well as preparation method and application of contact lens material
The porous structure hydrogel material formed by orthogonal crosslinking process solves the problem of poor optical performance of macromolecular biological protein contact lens materials, achieves high light transmittance and biocompatibility, and enhances the activity of biological agents and Treatment effect, providing versatile contact lens applications.
Patent Information
- Application Number
- CN202411320736.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-23
- Publication Date
- 2024-12-03
AI Technical Summary
When using macromolecular biological proteins as monomers, existing contact lens materials have poor optical performance, insufficient transparency and poor optical uniformity, which limits their application in the field of contact lenses.
The orthogonal crosslinking process is adopted to form a uniformly dispersed porous structure hydrogel through the preliminary polymerization and secondary crosslinking of macromolecular biological proteins, avoid the formation of optical interfaces, improve the optical properties of the material, and do not require additional stabilizers. Maintain protein drug activity in the case.
The high light transmittance, uniform refractive index and good biocompatibility of contact lens materials are achieved, which enhances the activity and therapeutic effect of biological agents, and provides functions to promote cell migration, corneal repair and dry eye treatment.
Smart Images

Figure CN119060271A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of biomaterials, and in particular to a contact lens material containing macromolecular bioprotein monomers, and a preparation method and application thereof. Background Art
[0002] Contact lenses are a widely used medical device, mainly used to improve vision or aesthetic needs. There are many types of contact lenses on the market to meet the needs of different users. The design and manufacture of these products take into account many factors, including the biocompatibility of materials, oxygen permeability, light transmittance and comfort for long-term wear.
[0003] In the preparation of contact lenses, macromolecular biological proteins have become a promising choice in material selection due to their excellent biocompatibility and versatility. This type of protein can not only improve the biological performance of contact lenses, but also provide the possibility of a variety of functional improvements such as drug delivery. However, attempts to use macromolecular proteins as one of the monomer materials face significant challenges. Traditionally, methods using such proteins as contact lens materials often result in poor optical properties of the final product, such as insufficient transparency and poor optical uniformity, which limits their application in the field of contact lenses. Due to the heterogeneity of the reaction process and the different refractive indices of the materials used, different optical interfaces will be produced. When the interface unit size is larger than the wavelength of light, the light path will be refracted and reflected at the interface, affecting its optical properties.
[0004] Existing research has focused on using bioproteins such as collagen as building blocks for hydrogels. Although these methods have shown potential in applications such as bioscaffolds, they have not been widely used in contact lens manufacturing due to limitations in optical properties. Therefore, there is an urgent need to develop a new method that can take advantage of the advantages of large molecular bioproteins while overcoming the limitations of traditional methods to produce contact lens materials that are both highly transmittance and biocompatible. Summary of the invention
[0005] In view of the deficiencies of the prior art, the purpose of the present invention is to provide a contact lens material containing macromolecular biological protein monomers and a preparation method and application thereof, aiming to prepare a contact lens material with excellent optical properties by using macromolecular biological protein as one of the effective material monomers through a specific orthogonal crosslinking process, the contact lens material uses a uniform dispersion and multi-step crosslinking method to make the material an isotropic crosslinked body, avoiding the problem of optical properties, using macromolecular biological protein as one of the effective material monomers, creating a porous structure hydrogel containing collagen, providing a good microscopic environment for biological preparations, and maintaining the activity of protein drugs without adding additional stabilizers and increasing the therapeutic effect through the synergistic effect of drugs and hydrogels. The purpose of the present invention is to provide a contact lens material containing macromolecular biological protein monomers, having good optical properties including transmittance, haze, and uniform refractive index, being able to load and promote the therapeutic effect of biological preparations, ensuring and improving the activity and therapeutic effect of biological preparations, and providing various special functions for contact lenses, promoting cell migration, promoting corneal repair, and treating dry eyes, etc.
[0006] To achieve the purpose of this invention, the present invention adopts the following technical scheme: a contact lens material containing macromolecular biological protein monomers, wherein the materials for preparing the contact lens material include one or more cross-linking monomers, cross-linking agents, initiators, activators and water; the cross-linking monomers contain at least one macromolecular biological protein. The contact lens material contains macromolecular proteins, which ensures anti-degradation performance, mechanical properties and optical properties, and can be loaded with biological agents without the need for specific stabilizers, thereby ensuring and improving the activity and therapeutic effect of biological agents, and providing various special functions for contact lenses, such as promoting cell migration, promoting corneal repair and treating dry eyes.
[0007] As a preferred embodiment of the contact lens material containing macromolecular biological protein monomers described in the present invention, the macromolecular biological protein comprises a biological protein containing two functional groups, amine and carboxyl, which is polymerized by reaction; the macromolecular biological protein comprises type I collagen, type II collagen, type III collagen, type IV collagen, type V collagen, type VII collagen, type X collagen, type XI collagen or serum albumin.
[0008] As a preferred embodiment of the contact lens material containing macromolecular biological protein monomers of the present invention, the macromolecular biological protein contains 0.01 to 10 wt % of collagen.
[0009] As a preferred embodiment of the contact lens material containing macromolecular biological protein monomers described in the present invention, the cross-linking monomer includes one or more polymer monomer structural components, and the polymer monomer structural components are ethylenically unsaturated carboxylic acids, (meth)acryloyloxy-substituted alcohols, vinyl lactone amines or acrylamide.
[0010] As a preferred embodiment of the contact lens material containing macromolecular biological protein monomers described in the present invention, the ethylenically unsaturated carboxylic acid includes methacrylic acid and acrylic acid, the (meth)acryloyloxy-substituted alcohol includes 2-hydroxyethyl methacrylate and 2-hydroxyethyl acrylate, the vinyl lactone amine includes N-vinyl pyrrolidone, and the acrylamide includes (meth)acrylamide and dimethylacrylamide.
[0011] As a preferred embodiment of the contact lens material containing macromolecular biological protein monomers described in the present invention, the crosslinking agent includes a biological protein crosslinking agent and its derivatives, a natural crosslinking agent, a natural polysaccharide or an enzyme crosslinking agent.
[0012] As a preferred embodiment of the contact lens material containing macromolecular biological protein monomers described in the present invention, the biological protein cross-linking agent includes BS^3 (Bis(sulfosuccinimidyl)butyramide), EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide), DTSSP (3,3'-dithiobis(4-sulfosuccinimidyl)propionic acid), DSS (disuccinimidylbutane), SMPB (succinimidyl 4-[N-maleimidomethyl]cyclohexane-1-carboxylate), EGS (ethylene glycol bis(succinimidyl)succinic acid) and the like and their derivatives; the natural cross-linking agent is tannic acid, (TGase) the natural polysaccharide is agarose or trehalose, and the enzyme cross-linking agent is transglutaminyl transferase.
[0013] As a preferred embodiment of the contact lens material containing macromolecular biological protein monomers of the present invention, the initiator is a photoinitiator that initiates free radical polymerization, and the photoinitiator includes benzophenone, phosphate, thiophene, photosensitive dye or quinone compounds. The activator is morpholineethanesulfonic acid.
[0014] As a preferred embodiment of the contact lens material containing macromolecular biological protein monomers described in the present invention, the contact lens material containing macromolecular biological protein monomers has anti-degradation performance, the contact lens material maintains protein activity time of not less than 20 under the condition of 5U / ml collagenase, the maximum load tensile strain of the contact lens material is not less than 50%, and the light transmittance of the contact lens material is not less than 60%.
[0015] As a preferred embodiment of the contact lens material containing macromolecular biological protein monomers described in the present invention, the contact lens material containing macromolecular biological protein monomers has good biocompatibility and a corneal cell migration promoting rate that is better than that of a single biological agent, the corneal cell migration promoting rate is not less than 5% in 24 hours, and the corneal cell migration promoting rate is not less than 15% in 48 hours.
[0016] As a preferred embodiment of the contact lens material containing macromolecular biological protein monomers described in the present invention, the contact lens material containing macromolecular biological protein monomers still has good biocompatibility and a corneal cell migration rate that is better than that of a single biological agent under hypertonic conditions (simulating a dry eye environment), the corneal cell migration rate is not less than 5% in 24 hours, and the corneal cell migration rate is not less than 15% in 48 hours.
[0017] The present invention utilizes macromolecular protein as a reactive monomer, performs preliminary polymerization on it, and forms a porous scaffold. In this process, most of the reactive functional groups of the macromolecular protein have reacted, thereby avoiding the formation of a large number of optical interfaces by reacting with other monomers in subsequent reactions. Afterwards, it is uniformly mixed with other reactive monomers, and other monomers are secondary cross-linked in the macromolecular protein polymer scaffold, and partially cross-linked on the protein surface. Through this process, the interface formation between different optical components is effectively controlled, and a hydrogel material with good optical properties is prepared.
[0018] On the other hand, the present invention provides a method for preparing a contact lens material containing a macromolecular biological protein monomer, the preparation method comprising the following steps: preparing a macromolecular protein monomer into a uniform solution A; preparing a macromolecular protein crosslinking agent, an initiator, and an activator into a uniform solution B, uniformly mixing and centrifuging with the above macromolecular solution to obtain a preliminarily cross-linked mixed solution C; and uniformly mixing and dissolving other reaction monomers to prepare a solution and adding a crosslinking agent to obtain a mixed solution D, which is then mixed with the above mixed solution C and the sample is transferred to a suitable mold; in the mold, a second crosslinking and shaping is performed using UV light to obtain the contact lens material.
[0019] As a preferred mode of the preparation method of the present invention, the preparation step of the solution A is: dissolving the finished collagen product in an acetic acid solution and keeping it in a liquid state in a metal bath to obtain solution A. That is, dissolving the finished collagen product in 500ul of a 0.1M acetic acid solution; keeping the solution in a 40°C metal bath to obtain solution A.
[0020] As a preferred mode of the preparation method of the present invention, the preparation steps of the solution B are as follows: N-hydroxysuccinimide and 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride are added to the morpholineethanesulfonic acid solution, mixed, put into a metal bath for activation, and sodium hydroxide solution is added and mixed to obtain solution B. That is, N-hydroxysuccinimide (NHS) and 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) are added to 500ul of morpholineethanesulfonic acid (MES) solution (PH5.5), mixed, put into a 40°C metal bath for activation for 10 minutes, and 100ul of 0.5M sodium hydroxide solution is added and mixed to obtain solution B.
[0021] As a preferred mode of the preparation method of the present invention, the preparation step of the solution C is: dissolving zwitterionic sulfobetaine methacrylate with a phosphate buffer solution, adding hydroxyethyl methacrylate and a cross-linking agent triethylene glycol dimethacrylate, and mixing well to obtain solution C. That is, 100 mg of zwitterionic sulfobetaine methacrylate (SBMA) is dissolved with 400 uL of 1X phosphate buffer solution (pbs), 650 uL of hydroxyethyl methacrylate (HEMA) and 10 uL of a cross-linking agent triethylene glycol dimethacrylate (TEGDMA) are added, and mixing well to obtain solution C.
[0022] As a preferred embodiment of the preparation method of the present invention, the preparation steps of solution D are as follows: solution A and solution B are mixed with a three-way pipe, quickly transferred to a 2 mL centrifuge tube, and centrifuged at 10000 rpm, 4°C, for 1 minute to obtain solution D.
[0023] As a preferred mode of the preparation method described in the present invention, after the mixed solution C and the mixed solution D are mixed, the sample is transferred to an appropriate mold, and the specific steps of using UV light for the second crosslinking and shaping are: D liquid is quickly sucked into C liquid with a pipette, shaken and mixed, photoinitiator Irgacure-2959 is added, mixed, and air bubbles are removed by ultrasound in a dark environment, and the mixed liquid is sucked into a film mold composed of two 1mm glass plates separated by a polytetrafluoroethylene gasket with a pipette; and it is placed under 365mm UV light for 30 minutes to form a gel.
[0024] As a preferred mode of the preparation method described in the present invention, the preparation method also includes the following steps: soaking the prepared gel in PBS for 1 hour until the gel can be detached from the glass plate; washing the hydrogel in PBS for 2 days to remove unreacted monomers; drying the hydrogel at 37°C for 24 hours, and soaking it in a growth factor solution to load the growth factor.
[0025] In another aspect, the present invention provides the use of the aforementioned contact lens material containing macromolecular biological protein monomers in the preparation of contact lenses, which are ocular medical devices. The ocular medical devices include artificial lenses, intraocular lenses, contact lenses, implantable contact lenses, corneal correctors, intracorneal lenses, corneal inserts, corneal rings or glaucoma filters.
[0026] In yet another aspect, the present invention provides a contact lens, wherein the material for preparing the contact lens comprises the contact lens material containing the macromolecular biological protein monomer described in the present invention.
[0027] The beneficial effects of the present invention are:
[0028] (1) The present invention provides a contact lens material containing a macromolecular biological protein monomer, which has good optical properties. The macromolecular biological protein contains a macromolecular protein and can be purposefully designed and modified to ensure biocompatibility. The macromolecular biological protein has the potential to be one of the reactive monomer materials. While ensuring and improving biocompatibility, it also provides contact lenses with various special functions including promoting cell migration, promoting repair, loading drugs, and maintaining drug activity with a short half-life.
[0029] (2) The present invention provides a contact lens material containing macromolecular biological protein monomers, which utilizes macromolecular biological protein as one of the effective material monomers to make the contact lens itself have more functionality, including repair performance, promotion of cell migration, treatment of dry eyes, and the performance of carrying biological agents and maintaining the activity of biological agents. Macromolecular proteins such as collagen can provide a good microenvironment for some protein drugs with short half-lives that are difficult to maintain activity, thereby realizing the possibility of loading and releasing more types of eye drops through contact lenses.
[0030] (3) The contact lens material provided by the present invention can be loaded with biological agents that promote the therapeutic effect. The biological agents can be loaded by simple immersion without the need for specific stabilizers (such as aFGF without the need for additional heparin), and the long-term activity and long-term slow release of the biological agents can still be maintained. The contact lens material uses a uniform dispersion and multi-step cross-linking method to make the material an isotropic cross-linked body, reducing or even avoiding the interface generated by the reaction of macromolecular proteins and polymers, avoiding the problem of optical properties, and can also provide protection and support for protein monomers to improve their stability. The mechanical properties and anti-protein degradation properties of the material are significantly improved by the protection and support of non-protein components.
[0031] (4) The present invention provides a method for preparing a contact lens material containing a macromolecular biological protein monomer, which uses a macromolecular biological protein as a reaction monomer to perform pre-crosslinking and accurately control the combination of protein and non-protein components. The orthogonal crosslinking process uses the macromolecular biological protein as one of the effective material monomers, effectively avoiding the generation of a protein-polymer interface, ensuring its optical properties, and preparing a contact lens material with excellent optical properties.
[0032] (5) The present invention provides a method for preparing a contact lens material containing a macromolecular biological protein monomer. Through a specific cross-linking process, the macromolecular biological protein is used as one of the effective material monomers to prepare a contact lens material with excellent optical properties. The material is made into an isotropic cross-linked body by uniform dispersion and multi-step cross-linking, thereby avoiding the problem of optical properties. The addition of macromolecular proteins makes the contact lens itself have more functionality, including anti-protein and cell adhesion properties, repair properties, promotion of cell migration, and drug loading and drug activity maintenance properties. The activity of some drugs with short half-lives that are difficult to maintain can be guaranteed by macromolecular proteins such as collagen, thereby realizing the possibility of loading and releasing more types of eye drops through contact lenses. BRIEF DESCRIPTION OF THE DRAWINGS
[0033] The accompanying drawings are used to provide a further understanding of the present invention and constitute a part of the specification. Together with the embodiments of the present invention, they are used to explain the present invention and do not constitute a limitation of the present invention. In the accompanying drawings:
[0034] Figure 1 This is a schematic diagram of a contact lens product according to the present invention;
[0035] Figure 2 A product appearance feature diagram of the contact lens of the present invention;
[0036] Figure 3 The FITR results indicate the presence of collagen characteristic peaks in the material (collagen);
[0037] Figure 4 The transmittance data show the high transmittance of the synthetic material;
[0038] Figure 5 The tensile strain data of the material is used to characterize its superior mechanical strength;
[0039] Figure 6 The material has good resistance to collagenase degradation; Figure 7 The scanning electron microscope (SEM) image shows the porous structure and pore size controllability of the material;
[0040] Figure 8 is the release capacity of the material for the growth factor aFGF;
[0041] Fig. 9 The material has good biocompatibility and cell proliferation promoting performance;
[0042] Fig.10 The material has a cell proliferation promoting performance superior to that of a single biological agent;
[0043] Fig.11 The material can still promote cell proliferation under dry eye conditions;
[0044] Fig.12 The material still has better cell proliferation-promoting performance than single biological agents under dry eye conditions;
[0045] Fig.13 The more intuitive repair performance of the material in the corneal cell scratch test is that it has various functionalities including repair performance;
[0046] Fig.14 It is a direct comparison between the material prepared by the method for preparing a contact lens material containing macromolecular biological protein monomers described in the invention and the material prepared by the traditional method. DETAILED DESCRIPTION
[0047] The scheme of the present invention will be explained below in conjunction with the embodiments. It will be appreciated by those skilled in the art that the following embodiments are only used to illustrate the present invention and should not be considered as limiting the scope of the present invention. Where specific techniques or conditions are not indicated in the embodiments, the techniques or conditions described in the literature in this area or the product specifications are used. The reagents or instruments used are not indicated by the manufacturer and are all conventional products that can be obtained commercially.
[0048] The present invention proposes an innovative solution, which aims to prepare a contact lens material with excellent optical properties by using a specific cross-linking process and using macromolecular biological proteins as one of the effective material monomers. The material is made into an isotropic cross-linked body by uniform dispersion and multi-step cross-linking, avoiding the problem of optical properties. The addition of macromolecular proteins makes the contact lens itself more functional, including anti-protein and cell adhesion properties, repair properties, cell migration promotion, and drug loading and drug activity maintenance properties. The activity of some drugs with short half-lives and difficult to maintain activity can be guaranteed by macromolecular proteins such as collagen, thereby realizing the possibility of loading and releasing more types of eye drops through contact lenses. In addition, by using macromolecular biological proteins as one of the effective material monomers, a porous structure hydrogel containing collagen is created, which provides a good microscopic environment for biological preparations, and the activity of protein drugs can be maintained without the addition of stabilizers, and the therapeutic effect can be increased by the synergistic effect of drugs and hydrogels. The protein substrate guarantees and improves the activity and therapeutic effect of biological preparations, and at the same time provides various special functions for contact lenses, such as drug loading, cell migration promotion, corneal repair promotion and treatment of dry eyes.
[0049] There have been quite a lot of studies and introductions on the preparation of contact lenses that can be loaded with drugs. However, the instability of macromolecular protein biologics makes it a significant challenge to combine them with contact lens materials. The structure of macromolecular proteins is complex and is easily affected by environmental factors such as temperature, pH, light, etc., and even slight changes in protein structure may lead to the loss of their activity. Therefore, the materials of contact lenses must have good biocompatibility and cannot have a destructive effect on the protein structure. Commonly used contact lens materials such as silicone hydrogels and polymers need to be modified or selected as specific types to better protect the structure and function of proteins. In addition, the drug loading method, such as adsorption, embedding or chemical grafting, needs to be carefully designed to minimize damage to the protein structure. For example, chemical grafting may require mild reaction conditions or specific chemical modifications to maintain the activity and structural integrity of the protein. Existing studies have focused on loading heparin-containing growth factor FGF into hydrogel materials for sustained release. Although these methods have shown potential in applications such as bioscaffolds, different types of biologics cannot be loaded under the conditions of the same material in a simple way because different biologics maintain their activity in different ways. Therefore, there is an urgent need to develop a new material that can load various easily inactivated biological agents by the simplest immersion method and release them slowly through contact lenses, thereby improving the efficacy of biological agents and thus improving patients' medical compliance and the treatment effect of ophthalmic diseases.
[0050] In terms of material selection, macromolecular biological proteins have become a promising choice due to their excellent biocompatibility and versatility. This type of protein can not only improve the biological performance of contact lenses, but also provide the possibility of a variety of functional improvements such as drug loading. However, attempts to use macromolecular proteins as one of the monomer materials face significant challenges. Traditionally, the method of using such proteins as contact lens materials often leads to poor optical properties of the final product, such as insufficient transparency and poor optical uniformity, which limits their application in the field of contact lenses. Due to the heterogeneity in the reaction process and the different refractive indices of the materials used, different optical interfaces will be produced. When the interface unit size is larger than the wavelength of light, the light path will refract and reflect at the interface, affecting its optical properties. At present, there are no similar patents proposing transparent colloids that can contain biological proteins and have certain mechanical strength and resistance to protein degradation. Previous research products have a series of problems including low mechanical strength, low transparency, inability to maintain long-term stability of proteins, and no biological proteins. Therefore, the present invention provides a contact lens material containing macromolecular biological protein monomers, which can not only utilize the advantages of macromolecular biological proteins, but also overcome the limitations of traditional methods. The contact lens material uses uniform dispersion and multi-step cross-linking to make the material an isotropic cross-linked body, avoiding the problems of optical performance and protein stability. The present invention provides a contact lens material that loads and promotes the therapeutic effect of biological agents. The cross-linking monomer contains at least one macromolecular biological protein and one or more high-molecular monomer structural components, and uses including but not limited to cross-linking agents, initiators, and activators. The contact lens material contains macromolecular proteins and can load biological agents without the need for specific stabilizers, thereby ensuring and improving the activity and therapeutic effect of biological agents, and providing various special functions for contact lenses, such as promoting cell migration, promoting corneal repair, and treating dry eyes. In addition, the material has good optical properties including transmittance, haze, and uniform refractive index, as well as anti-protein degradation properties.
[0051] The present invention provides a method for preparing a contact lens material containing a macromolecular biological protein monomer, and the preparation method comprises the following steps: The present invention provides a method for preparing a contact lens material containing a macromolecular biological protein monomer, and the preparation method comprises the following steps: preparing a macromolecular protein monomer into a uniform solution A; preparing a macromolecular protein crosslinking agent, an initiator, and an activator into a uniform solution B, uniformly mixing and centrifuging with the above macromolecular solution to obtain a preliminarily crosslinked mixed solution C; and uniformly mixing and dissolving other reaction monomers to prepare a solution and adding a crosslinking agent to obtain a mixed solution D, and then mixing with the above mixed solution C, and transferring the sample to an appropriate mold; in the mold, using UV light for a second crosslinking and shaping, the contact lens material can be obtained. The technical scheme of the present invention is further described below through examples.
[0052] Example 1
[0053] This embodiment is a contact lens material containing macromolecular biological protein monomers according to the present invention, and its preparation method comprises the following steps:
[0054] (1) Dissolve collagen (Beidi Bio, atelopeptiform porcine type I collagen) in 500 uL of 0.1 M acetic acid solution; keep the solution in a 40° C. metal bath to obtain solution A;
[0055] (2) Add N-hydroxysuccinimide (NHS) (98%, Shanghai Aladdin) and 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) (98%, Shanghai Aladdin) to 500 μl of morpholineethanesulfonic acid (MES) (Shanghai Aladdin) solution (pH 5.5), mix well, place in a 40°C metal bath for activation for 10 minutes, add 100 μl of 0.5 M sodium hydroxide solution, mix well, and obtain solution B;
[0056] (3) Dissolve 100 mg of zwitterionic sulfobetaine methacrylate (SBMA) (97%, Sigma-Aldrich) in 400 uL of 1X phosphate buffer solution (PBS), add 650 uL of hydroxyethyl methacrylate (HEMA) (96%, Shanghai Aladdin) and 10 uL of cross-linking agent triethylene glycol dimethacrylate (TEGDMA) (95%, Shanghai Aladdin), mix well, and obtain solution C;
[0057] (4) Mix solution A and solution B using a three-way tube, quickly transfer to a 2 mL centrifuge tube, and centrifuge at 10,000 rpm, 4°C for 1 minute to obtain solution D;
[0058] (5) After the solution D is mixed with the mixed solution C, the sample is transferred to a suitable mold; in the mold, UV light is used for a second crosslinking and shaping to obtain the contact lens material. The specific steps of mixing the mixed solution C with the mixed solution D, transferring the sample to a suitable mold, and using UV light for a second crosslinking and shaping are as follows: quickly aspirate the D solution into the C solution with a pipette, oscillate and mix, add the photoinitiator Irgacure-2959 (98%, Sigma-Aldrich), mix, remove bubbles by ultrasound in a dark environment, and aspirate the mixed liquid into a film mold composed of two 1 mm glass plates separated by a polytetrafluoroethylene gasket with a pipette; place it under 365 mm UV light for 30 minutes to form a gel;
[0059] (6) Soaking the prepared hydrogel in PBS for 1 hour until the hydrogel can be detached from the glass plate; washing the hydrogel in PBS for 2 days to remove unreacted monomers; drying the hydrogel at 37° C. for 24 hours to obtain a contact lens material containing macromolecular biological protein monomers;
[0060] According to the preparation steps (1) to (6) above, and in accordance with the specific formulas of different collagen contents described in Table 1, the contact lens material containing macromolecular biological protein monomers described in the present invention can be prepared.
[0061] Table 1 Specific formulas of different collagen contents
[0062]
[0063] Example 2
[0064] This embodiment is a schematic diagram of a contact lens material product containing a macromolecular biological protein monomer and a product appearance characteristic diagram according to the present invention, as shown in FIG. Figure 1 and Figure 2 As shown. Among them, Figure 1 This is a schematic diagram of a contact lens product according to the present invention; Figure 2 This is a diagram showing the product appearance characteristics of the contact lens described in the present invention.
[0065] Example 3
[0066] This example is a contact lens material containing macromolecular biological protein monomers according to the present invention subjected to Fourier transform infrared spectroscopy (FITR) analysis. The results are as follows: Figure 3 shown.
[0067] Experimental method: The sample was placed in -80℃ and frozen for 30min, placed in a freeze dryer and freeze-dried for 24h, then taken out and ground into powder using a mortar and pestle, and detected using a Thermo Fisher infrared spectrometer. HS mass ratio: HEMA:SBMA:collagen = 65:10:0; HSC10: HEMA:SBMA:collagen = 65:10:1; HSC20: HEMA:SBMA:collagen = 65:10:2; HSC30: HEMA:SBMA:collagen = 65:10:3; HSC40: HEMA:SBMA:collagen = 65:10:4, COL is pure collagen.
[0068] Experimental results: Figure 3 The FITR results show that the material contains characteristic peaks of collagen, indicating the presence of collagen in the material, and indicating that the preparation method can still preserve collagen without causing it to denature and degrade.
[0069] Example 4
[0070] This example is a data analysis of the transmittance of a contact lens material containing a macromolecular biological protein monomer according to the present invention.
[0071] Experimental method: Place the sample in a 96-well plate and set up a blank well. Add 100uL PBS to each well. Use an ELISA reader to record the OD value of 400-650nm in the visible spectrum and calculate the transmittance T. T is calculated by the following formula 1:
[0072] T=10^(-OD)*100%(1)
[0073] The transmittance T of HS, HSC5, HSC10, HSC20, HSC30 and HSC40 can be measured and calculated.
[0074] Experimental results: Figure 4 The transmittance data shows that the synthetic material has a high transmittance, which can be as high as over 98% in the visible spectrum. Although the transmittance will decrease to a certain extent with the increase of collagen concentration, it still meets the industry standard of contact lenses, which is greater than 92%.
[0075] Example 5
[0076] This embodiment is the water content, water contact angle, and oxygen permeability data of a contact lens material containing a macromolecular biological protein monomer described in the present invention, which is used to support that the material complies with the industry standards for contact lens materials.
[0077] Table 2
[0078]
[0079] Example 6
[0080] This example is a tensile modulus data analysis of a contact lens material containing a macromolecular biological protein monomer according to the present invention.
[0081] Experimental method: The hydrogel sample was cut into dumbbell-shaped hydrogel with a dumbbell-shaped annular cutter, fixed on the stretching machine, set the speed to 5 mm / min and started to measure the tensile strain under the maximum load of HS, HSC10, HSC20, HSC30 and HSC40.
[0082] Experimental results: Figure 5 The tensile modulus data of the material is used to characterize that the material still has excellent mechanical strength after adding macromolecular proteins that affect mechanical properties, and can meet the contact lens industry standard, that is, greater than 100%.
[0083] Example 7
[0084] This example is a collagen degradation experiment conducted on a contact lens material containing macromolecular biological protein monomers as described in the present invention.
[0085] Experimental method: Collagen degradation experiment: Fresh pig eyes were provided by Changsha pig breeding village. Pig corneas were dissected from fresh pig eyes and used as natural cornea group (NC) for standby. Collagenase (Solebo) powder was dissolved in PBS to prepare 5U / ml collagenase solution. 333mg sample was added to 4ml collagenase solution, protected from light, placed in a constant temperature shaker at 37℃ and 100rpm, and 500ul supernatant was taken at -80℃ for standby at 12h, 24h, 44h, 48h, 60h, 72h, 80h, and 100h. Collagenase was added to the solution every 12h to prevent collagenase inactivation and keep it at 5U / ml. The hydroxyproline concentration in the stored supernatant was detected using a hydroxyproline kit (Nanjing Jiancheng): standard solution was prepared, 500ul sample and 250ul digestion solution were mixed, and incubated at 37℃ for 3h. After adding the oxidant, mix thoroughly and let stand, then add dimethylaminobenzaldehyde, place in a 60°C water bath for 15 minutes, cool with running water, centrifuge at 3500 rpm for 10 minutes, and place in an ELISA reader to measure the OD value at 550 nm. The hydroxyproline concentration C can be calculated according to formula (1):
[0086] C (μg / ml) = (A (measurement) - A (blank)) / (A (standard) - A (blank)) * C (standard) (3)
[0087] Note: C (standard) = 5 μg / ml
[0088] Experimental results: Figure 6 The above is the generation curve of the degradation product hydroxyproline obtained by the degradation of collagen in 5U / ml collagenase. In the human body, collagen is indeed susceptible to degradation by collagenase, which is an important consideration for collagen-based materials used for implantation. By simulating extreme degradation conditions in a 5U / mL collagenase environment, the stability of the material in such an environment can be demonstrated. The time for the hydroxyproline release of natural porcine cornea (NC) in this environment to reach a peak is 48 hours, indicating that under such extreme conditions, the natural cornea will be completely degraded within 48 hours. In the HSC hydrogel group, the peak of the hydroxyproline release curve of the collagen-containing hydrogel appears at 60 hours, which shows that the HSC hydrogel has better resistance to enzyme degradation than the natural cornea. This shows that the present invention has good stability.
[0089] Example 8
[0090] This embodiment is an electron microscope scanning of a contact lens material containing macromolecular biological protein monomers described in the present invention.
[0091] Experimental method: The swollen samples were cut into small pieces and placed in a freeze dryer for 24 hours. The freeze-dried samples were attached to a metal bracket using conductive double-sided tape, sputtered with gold for 60 seconds, and placed in a HITACHI cold field emission scanning electron microscope for observation, and the surface and cross-section of the samples were photographed.
[0092] Experimental results: Figure 7 This is a scanning electron microscope (SEM) picture, which shows that the material has a porous structure. A comparison between HS (hydrogel without collagen) and HSC10 (hydrogel containing collagen) was performed, which shows that the pore size of the material can be significantly increased after the addition of macromolecular proteins.
[0093] Example 9
[0094] This example is a growth factor drug release experiment conducted on a contact lens material containing macromolecular biological protein monomers according to the present invention.
[0095] Experimental method: Dissolve aFGF and dry the hydrogel in a 37℃ oven for 24h. Place 1g of hydrogel in 3ml of aFGF solution containing 100ug, place in a 4℃ shaker, and shake at 100rpm for 72h to fully load the growth factor. Take out the prepared hydrogel (HSC-aFGF) containing growth factors from the liquid and absorb the excess liquid on the filter paper. Put HS-aFGF and HSC40-aFGF into a light-proof centrifuge tube containing 3ml PBS at a specification of 333mg (HSC-aFGF) / 3ml (PBS), put it in a 37℃ incubator, and take 200ul of supernatant at 1h, 6h, 24h, 48h, 72h, 120h, 168h, 240h, 336h, and 480h and store it at -80℃. After collecting the supernatant at all time points, slowly thaw at room temperature, centrifuge at 3000rpm for 1 minute after thawing, and take the supernatant. Use the (AFGF / FGF1) ELISA kit to complete the detection of aFGF content: first set up blank wells and standard wells to make a standard curve. Add the sample to the sample well, set up duplicate wells (n=4), seal the plate with a sealing membrane and incubate at 37°C for 1h. Discard the liquid, spin dry, add biotin-labeled antibody solution, and incubate at 37°C for 1h. Discard the liquid, spin dry, add washing solution to wash 4-6 times, spin dry, and pat dry on filter paper, add enzyme conjugate solution, and incubate at 37°C for 30min. Discard the liquid, spin dry, wash 4-6 times, add color development solution to color for 20min, then add stop solution, use an enzyme reader to read the OD value at a wavelength of 450nm and use the standard curve to convert to obtain the concentration.
[0096] Experimental results: Figure 8By introducing collagen into HSC hydrogel, it can be seen that the drug loading capacity of the hydrogel is significantly improved. HSC40 is able to release more aFGF, and the release time exceeds 14 days, and the total concentration released is twice that of HS hydrogel without the introduction of collagen network. This shows that collagen not only enhances the water retention and physical stability of the hydrogel, but also improves its effectiveness as a drug carrier, and can provide more sustained and higher concentration drug release. In addition, as a macromolecular protein that is easily inactivated, the stability of aFGF in many drug delivery systems is an important challenge. HSC hydrogel can not only prolong the release time of growth factors, but also maintain their biological activity, which is critical for promoting the repair and regeneration of damaged tissues.
[0097] Example 10
[0098] This example is an analysis of the cell biocompatibility and corneal epithelial cell migration rate of a contact lens material containing a macromolecular biological protein monomer described in the present invention for live and dead cell staining
[0099] Experimental methods: 5*10^3 corneal epithelial cells were added to a 12-well plate and cultured for 24 hours. Growth factor solution and hydrogel extract were added according to different groups. Live and dead cell staining reagent (Yeasen) was added for staining after 24 hours and 48 hours, and observed under an inverted fluorescence microscope. The CON group was the normal culture group, the aFGF group was the group that continued to be cultured after adding DMEM / F12 (Gibco) containing aFGF after 24 hours of culture, and the HSC10-aFGF group was the group that continued to be cultured after adding hydrogel extract containing HSC10-aFGF after 24 hours of culture.
[0100] Experimental results: Fig. 9 It is shown that the contact lens material prepared by the present invention has good cell biocompatibility and cell proliferation promoting performance. It can be seen that the simple aFGF solution and the HSC hydrogel containing aFGF (HSC10-aFGF) have few dead cells in the live and dead cell staining experiment, and all of them are active living cells in the field of vision, which means that these hydrogel materials will not cause cell death and can support the survival of corneal epithelial cells. Fig.10 The results showed that the cell proliferation in the HSC10-aFGF group was more active, and there was a statistical difference compared with the group using aFGF alone, indicating that the cell proliferation promoting performance of the present invention is superior to that of a single biological agent.
[0101] Embodiment 11
[0102] This example is an analysis of the cell biocompatibility and corneal epithelial cell migration rate of a contact lens material containing a macromolecular biological protein monomer described in the present invention under hypertonic conditions for live and dead cell staining
[0103] Experimental method: 5*10^3 corneal epithelial cells were added to a 12-well plate, and then stimulated with 90nm sodium chloride for 24 hours after static culture for 24 hours, washed with PBS 3 times, and added with growth factor solution and hydrogel extract according to different groups. After 24 hours and 48 hours, live and dead cell staining reagent (Yeasen) was added for staining, and observed under an inverted fluorescence microscope. The CON group was the normal culture group, the aFGF group was the group that continued to be cultured after 24 hours of culture with DMEM / F12 (Gibco) containing aFGF, and the HSC10-aFGF group was the group that continued to be cultured after 24 hours of culture with hydrogel extract containing HSC10-aFGF.
[0104] Experimental results: Fig.11 It is shown that the contact lens material prepared by the present invention still has good cell biocompatibility under hypertonic conditions, that is, an environment simulating dry eyes. Fig.12 It is shown that under hypertonic conditions, the proliferation of HSC10-aFGF cells is more obvious than that of the aFGF group, indicating that the present invention also has the effect of treating dry eyes, and the therapeutic effect is better than that of using aFGF alone.
[0105] Example 12
[0106] This example is an analysis of the repair performance of a contact lens material containing a macromolecular biological protein monomer according to the present invention in a corneal cell scratch experiment.
[0107] Experimental method: 1*10^4 corneal epithelial cells were seeded in a 6-well plate and cultured for 24 hours. A 1mL pipette tip was used to draw a line in the center of the well. After washing with PBS, the basal medium containing hydrogel extract was added to continue the culture. The CON group was the normal culture group, the aFGF group was the group that continued the culture by adding the basal medium containing aFGF after drawing a line, and the HSC10-aFGF group was the group that continued the culture by adding the basal medium containing the hydrogel extract containing HSC10-aFGF after drawing a line.
[0108] Experimental results: Fig.13 The material has the ability to promote cell migration and repair performance in the corneal cell scratch experiment, and has various functionalities including repair performance.
[0109] Embodiment 13
[0110] A: Using the method for preparing a contact lens material containing a macromolecular biological protein monomer mentioned in the present invention, a transparent product can be obtained. Fig.14 (A);
[0111] B: Collagen, zwitterions, morpholineethanesulfonic acid, N-hydroxysuccinimide, 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride, hydroxyethyl methacrylate, and triethylene glycol dimethacrylate are put into the reaction and illuminated to obtain an opaque product. Fig.14 (B).
[0112] Fig.14 The results show that if the contact lens material containing macromolecular biological protein monomers provided by the present invention is not used, transparent macromolecular protein-containing products cannot be obtained, and only opaque products can be obtained. The preparation method of the contact lens material containing macromolecular biological protein monomers provided by the present invention can significantly improve the problem of not being able to maintain transparency in the preparation of composite hydrogels containing macromolecular proteins, and successfully prepares a transparent material containing macromolecular proteins with certain mechanical strength.
[0113] Although the embodiments of the present invention have been shown and described above, it is to be understood that the above embodiments are exemplary and are not to be construed as limitations of the present invention. A person skilled in the art may change, modify, replace and vary the above embodiments within the scope of the present invention.
Claims
1. A contact lens material containing macromolecular biological protein monomers, characterized in that: The materials for preparing the contact lens material include one or more cross-linking monomers, a cross-linking agent, an initiator, an activator and water; the cross-linking monomer contains at least one macromolecular biological protein.
2. The contact lens material containing macromolecular biological protein monomers as claimed in claim 1, characterized in that: The macromolecular biological protein comprises a biological protein containing two functional groups, amine and carboxyl, which is polymerized by reaction; the macromolecular biological protein comprises type I collagen, type II collagen, type III collagen, type IV collagen, type V collagen, type VII collagen, type X collagen, type XI collagen or serum albumin.
3. The contact lens material containing macromolecular biological protein monomers as claimed in claim 2, characterized in that: The macromolecular biological protein contains 0.01-10wt% collagen.
4. The contact lens material containing macromolecular biological protein monomers as claimed in claim 1, characterized in that: The cross-linking monomer includes one or more polymer monomer structural components, and the polymer monomer structural components are ethylenically unsaturated carboxylic acids, (meth)acryloyloxy-substituted alcohols, vinyl lactone amines or acrylamides.
5. The contact lens material containing macromolecular biological protein monomers as claimed in claim 4, characterized in that: The ethylenically unsaturated carboxylic acids include methacrylic acid and acrylic acid, the (meth)acryloyloxy-substituted alcohols include 2-hydroxyethyl methacrylate and 2-hydroxyethyl acrylate, the vinyl lactone amines include N-vinyl pyrrolidone, and the acrylamides include (meth)acrylamide and dimethylacrylamide.
6. The contact lens material containing macromolecular biological protein monomers according to claim 1, characterized in that: The cross-linking agent includes biological protein cross-linking agent and its derivatives, natural cross-linking agent, natural polysaccharide or enzyme cross-linking agent.
7. The contact lens material containing macromolecular biological protein monomers according to claim 6, characterized in that: The biological protein cross-linking agent includes Bis (sulfosuccinimidyl) butyramide, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide, 3,3'-dithiobis (4-sulfonic acid succinimidyl) propionic acid, disuccinimidyl butane, succinimidyl 4-[N-maleimidomethyl] cyclohexane-1-carboxylate or ethylene glycol bis (succinimidyl) succinic acid; the natural cross-linking agent is tannic acid, the natural polysaccharide is agarose or trehalose, and the enzyme cross-linking agent is transglutaminyl transferase.
8. The contact lens material containing macromolecular biological protein monomers according to claim 1, characterized in that: The initiator is a photoinitiator for initiating free radical polymerization reaction, and the photoinitiator includes benzophenone, phosphate, thiophene, photosensitive dye or quinone compound. The activator is morpholineethanesulfonic acid.
9. The contact lens material containing macromolecular biological protein monomers according to claim 1, characterized in that: The contact lens material containing macromolecular biological protein monomers has anti-degradation performance. Under the condition of 5U / ml collagenase, the contact lens material maintains protein activity for not less than 20 minutes. The maximum load tensile strain of the contact lens material is not less than 50%, and the light transmittance of the contact lens material is not less than 60%.
10. The contact lens material containing macromolecular biological protein monomers according to claim 1, characterized in that: The contact lens material containing macromolecular biological protein monomers has good biocompatibility and a corneal cell migration promoting rate that is superior to that of a single biological agent. The corneal cell migration promoting rate is not less than 5% in 24 hours and not less than 15% in 48 hours.
11. The contact lens material containing macromolecular biological protein monomers according to claim 1, characterized in that: The contact lens material containing macromolecular biological protein monomers still has good biocompatibility under hypertonic conditions and a corneal cell migration promoting rate that is superior to that of a single biological agent, wherein the corneal cell migration promoting rate is not less than 5% in 24 hours and not less than 15% in 48 hours.
12. A method for preparing a contact lens material containing macromolecular biological protein monomers, characterized in that: The contact lens material containing macromolecular biological protein monomers is the contact lens material according to any one of claims 1 to 11, and the preparation method comprises the following steps: The macromolecular protein monomer is prepared into a uniform solution A; the macromolecular protein cross-linking agent, initiator, and activator are prepared into a uniform solution B, which is uniformly mixed with the above macromolecular solution and centrifuged to obtain a preliminarily cross-linked mixed solution C; and other reaction monomers are uniformly mixed and dissolved to prepare a solution and a cross-linking agent is added to obtain a mixed solution D, which is then mixed with the above mixed solution C and the sample is transferred to a suitable mold; in the mold, UV light is used for a second cross-linking and shaping to obtain the contact lens material.
13. The preparation method according to claim 12, characterized in that: The preparation steps of the solution A are as follows: dissolving the finished collagen product in an acetic acid solution and keeping the solution in a metal bath in a liquid state to obtain the solution A; The preparation steps of the solution B are as follows: adding N-hydroxysuccinimide and 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride to the morpholineethanesulfonic acid solution, mixing well, placing in a metal bath for activation, adding sodium hydroxide solution, mixing well, and obtaining the solution B.
14. The preparation method according to claim 13, characterized in that: The concentration of the acetic acid solution is 0.1M, and 500uL of the acetic acid solution is used; The dosage of the morpholineethanesulfonic acid solution is 500uL, and the pH value of the morpholineethanesulfonic acid solution is 5.5; The temperature of the metal bath is 40°C; The concentration of the sodium hydroxide solution is 0.5M, and the dosage of the sodium hydroxide solution is 100uL.
15. The preparation method according to claim 12, characterized in that: The preparation steps of the solution C are as follows: dissolving zwitterionic sulfobetaine methacrylate with a phosphate buffer solution, adding hydroxyethyl methacrylate and a crosslinking agent, triethylene glycol dimethacrylate, and mixing well to obtain the solution C.
16. The preparation method according to claim 15, characterized in that: The dosage of the sulfobetaine methacrylate is 100 mg, the dosage of the phosphate buffer solution is 400 uL, the concentration of the phosphate buffer solution is 1X, the dosage of the hydroxyethyl methacrylate is 650 uL, and the dosage of the triethylene glycol dimethacrylate is 10 uL.
17. The preparation method according to claim 12, characterized in that: The preparation steps of the solution D are as follows: solution A and solution B are mixed with a three-way tube, quickly transferred to a 2 mL centrifuge tube, and centrifuged at 10000 rpm, 4° C., for 1 minute to obtain solution D.
18. The preparation method according to claim 12, characterized in that: After the mixed solution C and the mixed solution D are mixed, the sample is transferred to an appropriate mold, and the specific steps of using UV light for the second cross-linking and shaping are as follows: the D solution is quickly aspirated into the C solution with a pipette, shaken and mixed, the photoinitiator Irgacure-2959 is added, mixed, and air bubbles are removed by ultrasound in a dark environment. The mixed liquid is aspirated into a film mold composed of two 1 mm glass plates separated by a polytetrafluoroethylene gasket with a pipette; and it is placed under 365 mm UV light for 30 minutes to form a gel.
19. The preparation method according to claim 18, characterized in that: The preparation method also includes the following steps: soaking the prepared gel in PBS for 1 hour until the gel can be detached from the glass plate; washing the hydrogel in PBS for 2 days to remove unreacted monomers; drying the hydrogel at 37° C. for 24 hours, and soaking it in a growth factor solution to load the growth factor.
20. Use of the contact lens material containing macromolecular biological protein monomers according to any one of claims 1 to 11 in the preparation of ocular medical devices.
21. The use according to claim 20, characterized in that The ocular medical device includes an intraocular lens, an intraocular lens, a contact lens, an implantable contact lens, a corneal corrector, an intracorneal lens, a corneal inlay, a corneal ring or a glaucoma filter.
22. A contact lens, characterized in that: The material for preparing the contact lens comprises the contact lens material containing macromolecular biological protein monomers as described in any one of claims 1 to 11.
